
On Operation Mockingbird…




More evidence against the unexpected and unprecedented world and WHO response to the crisis in 2020 is provided in this 91-page 2019 WHO report entitled “Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza”. The word “lockdown” (one form of a non-pharmaceutical intervention or NPI) does not appear in this report. Nor does the WHO report even recommend masks (a favourite 2020 NPI) in case of an epidemic, though it does advocate their use for symptomatic individuals.
On the effect of NPIs, the report stated: “The evidence base on the effectiveness of NPIs in community settings is limited, and the overall quality of evidence was very low for most interventions. There have been a number of high-quality randomised controlled trials (RCTs) demonstrating that personal protective measures such as hand hygiene and face masks have, at best, a small effect on influenza transmission, although higher compliance in a severe pandemic might improve effectiveness” (emphasis added). Yet, for COVID-19, NPIs were recommended in bundles by WHO and other experts.
As is universally acknowledged, the WHO is the apex body for advice and guidance for health problems. It houses leading epidemiological experts and before COVID, they were advocating policies reminiscent of earlier confrontations with viruses.
Given this history, it remains a mystery as to why the world entered into a lockdown. In my paper, I report the result of various studies on the effectiveness of lockdowns; except for a few, most of these studies report that the lockdowns were highly successful in saving hundreds of thousands of lives. Since the average death rate from COVID is 2.5 per cent, these results imply that somewhere between 10 to 20 million less infections resulted from this unnatural experiment.

A Boston doctor suffered a serious allergic reaction to Moderna’s coronavirus vaccine, the first of its kind documented, a report said Friday.
Dr. Hossein Sadrzadeh, a geriatric oncologist at Boston Medical Center, became dizzy and felt his heart racing minutes after receiving the vaccine on Thursday, he told The New York Times.
“It was the same anaphylactic reaction that I experience with shellfish,” Dr. Sadrzadeh told the paper, noting that his tongue became numb, his blood pressure plummeted and he broke into a cold sweat.
“I don’t want anybody to go through that.”

Two Canadian researchers think that a special strain of cannabis might potentially be a valuable tool in the fight against COVID-19.
The researchers, Olga and Igor Kovalchuck have reportedly been developing and testing a novel cannabis strain for years, except with the goal of creating a strain that helps to combat cancer and inflammation. When the pandemic hit, the duo started to focus their efforts on how the strain might be used to help fight COVID-19.
The duo’s work was published in an April issue of the online medical journal Preprints.
“Similar to other respiratory pathogens, SARS-CoV2 is transmitted through respiratory droplets, with potential for aerosol and contact spread. It uses receptor-mediated entry into the human host via angiotensin-converting enzyme II (ACE2) that is expressed in lung tissue, as well as oral and nasal mucosa, kidney, testes, and the gastrointestinal tract,” reads the study. “Modulation of ACE2 levels in these gateway tissues may prove a plausible strategy for decreasing disease susceptibility.”
After looking at the research done on cannabis and COVID by other scientists, they were able to determine that cannabis, a special strain in particular, could potentially block COVID-19 from entering a person’s body to begin with.
It all comes down to our body’s ACE2 receptors, which works sort of like doorways into our bodies for the virus. In the case of the Kovalchuck’s work, cannabis would be used to decrease the level of ACE2 gene expression, essentially temporarily closing the doors to the virus.


You must be logged in to post a comment.